Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar jmacn22 (71.00) Submitted: 2/5/2009 1:18:07 PM : Underperform Start Price: $19.42 ALXN Score: -314.47

Underperform

Featured Broker Partners


Advertisement